Status:

TERMINATED

Catheter Thrombectomy in Patients With Massive Pulmonary Embolism

Lead Sponsor:

Straub Medical AG

Conditions:

Pulmonary Embolism

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

Official Title: Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism Study Population: Patients \>/= 18 years of age with massive pulmonary embolism su...

Detailed Description

Official Title: Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism Principal Investigator: Nils Kucher, MD, Cardiovascular Division, Interventional C...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients \>= 18 years of age with pulmonary embolism and cardiogenic shock, defined as a systolic arterial pressure \<= 90 mmHg, a drop in systolic arterial pressure \>= 40 mmHg for \>= 15 minutes, or ongoing administration of catecholamines for systemic arterial hypotension
  • Subtotal or total filling defect in the left and/or right main pulmonary artery due to massive PE, as assessed by chest computed tomography or by conventional pulmonary angiography
  • Right ventricular dysfunction on echocardiography: RV systolic hypokinesis and/or RV dilation (optional)
  • Failed thrombolysis or at least one of the following contraindications to PE thrombolysis present:
  • Active bleeding
  • History of intracranial bleeding
  • Surgery, delivery, organ biopsy, puncture of a non-compressible vessel within 10 days
  • History of stroke
  • Gastrointestinal bleeding within 10 days
  • Significant trauma within 15 days
  • Head injury requiring hospitalization within 1 year
  • Active cancer with known hemorrhagic risk
  • Neurosurgery or ophthalmologic surgery within the past year
  • Platelets \< 50,000 or INR \>2.0
  • Pregnancy
  • Exclusion Criteria
  • Systemic (paradoxical) embolism in the presence of an atrial septal defect or patent foramen ovale
  • Free floating right heart thrombi, left heart thrombi
  • Life expectancy due to underlying disease less than one month

Exclusion

    Key Trial Info

    Start Date :

    October 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2007

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT00314002

    Start Date

    October 1 2005

    End Date

    April 1 2007

    Last Update

    August 7 2009

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    Herz-Gefässklinik Bad Neustadt

    Bad Neustadt an der Saale, Germany, 97616

    2

    Klinik für Diagnostische Radiologie Christian-Albrechts-Universität Kiel

    Kiel, Germany, 24105

    3

    Universität Leipzig Herzzentrum

    Leipzig, Germany, 04289

    4

    Otto-von-Guericke-Universität Magdeburg

    Magdeburg, Germany, 39120